-
Product Insights
NewPost-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Traumatic Stress Disorder (PTSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical...
-
Product Insights
NewDementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
GlobalData's clinical trial report, “Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial...
-
Sector Analysis
NewLewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in LBD therapeutics. • There will be more than 1.1 million diagnosed prevalent cases of LBD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. • Currently, there are three marketed products for the treatment of LBD. • R&D activity within the LBD space is negligible, with no pipeline products in late-stage clinical development. • Commercial sponsors dominate clinical trial development in LBD, with the...
-
Sector Analysis
NewBody Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Report Overview Body dysmorphic disorder (BDD), also known as dysmorphophobia, is a severe psychiatric condition in which an individual spends a significant amount of time worrying about flaws in their own or another person’s appearance. These flaws are frequently overlooked by others. BDD can affect people of any age, but it is most common in teenagers and young adults. It affects both men and women. The BDD marketed and pipeline drugs market...
-
Product Insights
NewObsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Obsessive-Compulsive Disorder Clinical Trials Market Report Overview The Obsessive-Compulsive Disorder clinical trial market research report provides an overview of the Obsessive-Compulsive Disorder clinical trials scenario. The report provides top-line data relating to the clinical trials on Obsessive-Compulsive Disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Sector Analysis
NewMultiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Multiple Sclerosis Market Report Overview Multiple sclerosis (MS) disease-modifying therapies (DMTs) market size across the 7MM was valued at $18.9 billion in 2020 and is expected to achieve a CAGR of more than 4% during 2020-2030. The multiple sclerosis market research report provides an analysis of the current and future market competition in the global MS therapeutics market. The report also offers an insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide...
-
Sector Analysis
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Obsessive-Compulsive Disorder Marketed and Pipeline Drugs Report Overview Obsessive-compulsive disorder (OCD) is a disorder where repetitive behaviors such as hand washing/cleaning, checking on things, mental acts like counting, or other activities can significantly interfere with a person’s daily activities and social interactions. Although the cause of OCD is not very clear, certain genetic factors like a mutation in the human serotonin transporter gene (hSERT) can trigger OCD, as can several environmental factors, autoimmune disorders such as pediatric autoimmune neuropsychiatric disorder...
-
Product Insights
Alzheimer’s Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Alzheimer’s Disease Clinical Trials Market Report Overview The Alzheimer’s Disease clinical trial market research report provides an overview of Alzheimer’s Disease clinical trials scenario. The report provides top-line data relating to the clinical trials on Alzheimer’s Disease. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
ADHD Clinical Trials Market Report Overview The ADHD clinical trial market research report provides an overview of ADHD clinical trials scenario. The report provides top-line data relating to the clinical trials on ADHD. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
ET Marketed and Pipeline Drugs Report Overview Essential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking in the hands, head, trunk, voice, or legs. It is one of the most common trembling disorders and is frequently confused with Parkinson's disease (PD). ET is common among people older than 40, but it can affect people at any age. The ET marketed and pipeline drugs market research report includes an assessment of the disease, leading marketed products with...
-
Product Insights
Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Postherpetic Neuralgia Clinical Trials Market Report Overview The Postherpetic Neuralgia Clinical Trial provides an overview of Postherpetic Neuralgia Clinical trials scenario. The report provides top line data relating to the clinical trials on Postherpetic Neuralgia. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Cognitive Impairment Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Cognitive Impairment Clinical Trials Market Report Overview In total there were 1,537 clinical trials conducted on cognitive impairment, as of February 2023, of which the majority of them were conducted in Asia-Pacific. The cognitive impairment clinical trial market research report provides an overview of the clinical trials scenario. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
Parkinson’s Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Parkinson’s Disease Clinical Trials Market Report Overview In total there were 2,622 clinical trials conducted on Parkinson's Disease, as of February 2023, of which the majority of clinical trials were in Europe. The Parkinson’s Disease clinical trial market research report provides an overview of the clinical trials scenario. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 &...
-
Sector Analysis
Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Opioid Use Disorder Marketed and Pipeline Drugs Report Overview Opioid Use Disorder is a chronic neurological disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs and prolonged self-administration of opioid drugs. As the brain adapts to prolonged opioid use, the patient's tolerance increases, so a higher dose of opioid is needed to stimulate the mesolimbic system in the same way as the original dose. The Opioid Use Disorder marketed and pipeline drugs market research report...
-
Sector Analysis
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Diabetic Neuropathic Pain Market Overview The drug sales across the 7 major markets (7MM) in the Diabetic Neuropathic Pain (DNP) market were estimated at $1.7 billion in 2021. The DNP market is expected to grow at a CAGR of over 5% during 2021-2031. The US market makes up the majority of total global sales, due to the large DNP prevalent population and the high price of medication in the country. The diabetic neuropathic pain market research report provides an analysis...
-
Product Insights
Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Huntington Disease Clinical Trials Market Report Overview The Huntington disease clinical trial market research report provides an overview of the Huntington disease clinical trials scenario. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Friedreich Ataxia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Friedreich Ataxia Clinical Trials Market Report Overview The Friedreich Ataxia clinical trial market research report provides an overview of the Friedreich Ataxia clinical trials scenario. The report provides top-line data relating to the clinical trials on Friedreich Ataxia. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Multiple Sclerosis Clinical Trials Market Report Overview The multiple sclerosis clinical trial market research report provides an overview of the multiple sclerosis clinical trials scenario. The report provides top-line data relating to the clinical trials on multiple sclerosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Tourette Syndrome Clinical Trials Market Report Overview The tourette syndrome clinical trial market research report provides an overview of the tourette syndrome clinical trial scenario. The report provides top-line data relating to the clinical trials on tourette syndrome. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Report Overview Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a type of acquired immune-mediated disorder that affects the myelin components of the peripheral nervous system. Â CIDP can be monophasic, relapsing, or progressive, developing over eight weeks. People with CIDP experience fatigue, muscle weakness, and a loss of feeling symmetrically in their arms and legs that tends to slowly worsen over time. The CIDP marketed and pipeline drugs market research report provides a...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.